COMMUNICATIONS
J 4.8 Hz, 2H), 2.65 (t, J 4.8 Hz, 2H); 13C NMR (300 MHz, CD3CN):
d 193.7, 153.3, 142.4, 124.1, 121.9, 119.2, 112.0, 96.1, 90.2, 89.7, 87.4, 86.9,
65.6, 54.2, 50.9. FAB-MS (fast-atom bombardment mass spectrometry):
[M ] 567.8 (567).
[(R-Cp)99mTc(CO)3]: The starting material [99mTc(OH2)3(CO)3] (3a) was
prepared as described elsewhere.[12, 22] An aqueous solution of 7, for
example, in phosphate buffer was added to 3a (final concentration of 7
10 3 ± 10 4 m). Subsequent heating at 958C for 15 min afforded
[(R-Cp)99mTc(CO)3] in overall yields >95%. The HPLC retention times
for 8 and 10 are 21.9 and 20.5 min, respectively.
For the one-pot synthesis of 8 or 10 (M 99mTc), a vial was charged with 11
(4 mg, reducing agent and CO source) and Na2B4O7 (5.5 mg), sealed and
flushed with dry N2. Generator eluate (2 cm3) containing [99mTcO4] was
added, followed by an aqueous solution of 4. Heating at 908C for about
40 min gave 8 or 10 in high yields (ꢀ80% and ꢀ20% reduced form). The
yield and time course of the reaction were not influenced by the total
amount of radioactivity (up to 20 GBq of 99mTc).
Scheme 4. One- and two-step synthesis of complexes 8 and 10 (99mTc)
directly in water and [99mTcO4] . Reagents and conditions: a) CO (1 atm),
NaBH4, pH 12 or K2[H3BCO2] only, >98%. b) 4 or 7 (0.1 ± 1 mmol), 15 min
908C, >98%. c) 0.1 ± 1 mmol 4 or 7, K2[H3BCO2] (11; 4 mg), Na2B4O7,
pH 10, 40 min 908C, >95%.
Besides the major product, a second complex was formed in
minor amounts, with a similar retention time. It is likely that
11 reduced the carbonyl group in 8 to a hydroxy group.
We assume that the one-pot reaction is consecutive
Received: April 3, 2001 [Z16895]
[
99mTcO4] !3a !8 or 10. All the compounds labeled with
[1] S. S. Jurisson, D. Berning, W. Ja, D. Ma, Chem. Rev. 1993, 93, 1137 ±
1156.
[2] J. R. Dilworth, S. J. Parrott, J. Chem. Soc. Rev. 1998, 27, 43 ± 55.
[3] N. Metzler-Nolte, Angew. Chem. 2001, 113, 1072 ± 1076; Angew. Chem.
Int. Ed. 2001, 40, 1040 ± 1043.
[4] S. S. Jurisson, J. D. Lydon, Chem. Rev. 1999, 2205 ± 2218.
[5] M. J. Abrams, A. Davison, A. G. Jones, C. E. Costello, H. Pang, Inorg.
Chem. 1983, 22, 2798 ± 2800.
99mTc were stable in phosphate buffer for at least 24 h at 378C
without any significant decomposition, thus confirming the
highly robust nature of [(R-Cp)M(CO)3].
We demonstrated herein that half-sandwich complexes
[(R-Cp)M(CO)3] can easily be synthesized if the acid
dissociation constant of the cyclopentadiene ring is increased.
[6] G. Jaouen, S. Top, A. Vessieres, R. Alberto, J. Organomet. Chem. 2000,
600, 23 ± 36; G. Jaouen, A. Vessieres, I. S. Butler, Acc. Chem. Res.
1993, 26, 361 ± 369; A. D. Ryabov, Angew. Chem. 1991, 103, 945 ± 955;
Angew. Chem. Int. Ed. Engl. 1991, 30, 931 ± 941; K. H. Dötz, R.
Ehlenz, Chem. Eur. J. 1997, 3, 1751 ± 1756; K. Severin, R. Bergs, W.
Beck, Angew. Chem. 1998, 110, 1722 ± 1743; Angew. Chem. Int. Ed.
1998, 37, 1634 ± 1654.
[7] S. Top, H. Elhafa, A. Vessieres, J. Quivy, J. Vaissermann, D. W.
Hughes, M. J. McGlinchey, J. P. Mornon, E. Thoreau, G. Jaouen, J.
Am. Chem. Soc. 1995, 117, 8372 ± 8380.
The reaction of acetyl cyclopentadiene and derivatives with
[
99mTc(OH2)3(CO)3] directly yielded the radiopharmaceuti-
cally relevant complexes [(R-Cp)99mTc(CO)3] in good yields.
The major impact of this work emerges from the general
possibility of introducing the very small and highly lipophilic
[Cp99mTc(CO)3] moiety in a wide variety of small receptor-
binding biomolecules. Furthermore, the direct reaction of
acidic and water-soluble cyclopentadiene compounds with
aqua ions could lead to interesting and novel species in
aqueous organometallic chemistry.
[8] M. Salmain, M. Gunn, A. Gorfti, S. Top, G. Jaouen, Bioconjugate
Chem. 1993, 4, 425 ± 433; T. W. Spradau, J. A. Katzenellenbogen,
Bioconjugate Chem. 1998, 9, 765 ± 772.
[9] M. Wenzel, J. Labelled Compd. Radiopharm. 1992, 31, 641 ± 650.
[10] T. W. Spradau, J. A. Katzenellenbogen, Organometallics 1998, 17,
2009 ± 2017; F. Minutolo, J. A. Katzenellenbogen, J. Am. Chem. Soc.
1998, 120, 4514 ± 4515; F. Minutolo, J. A. Katzenellenbogen, Angew.
Chem. 1999, 111, 1730 ± 1732; Angew. Chem. Int. Ed. 1999, 38, 1617 ±
1620.
[11] T. W. Spradau, W. B. Edwards, C. J. Anderson, M. J. Welch, J. A.
Katzenellenbogen, Nucl. Med. Biol. 1999, 26, 1 ± 7.
[12] R. Alberto, R. Schibli, A. Egli, U. Abram, T. A. Kaden, P. A.
Schubiger, J. Am. Chem. Soc. 1998, 120, 7987 ± 7989.
[13] C. P. Casey, J. M. OꢁConnor, K. J. Haller, J. Am. Chem. Soc. 1985, 107,
1241; L. U. Gron, K. J. Haller, A. B. Ellis, J. Organomet. Chem. 1987,
323, 207 ± 217.
[14] R. D. Rogers, J. L. Atwood, M. D. Rausch, D. W. Macomber, W. P.
Hart, J. Organomet. Chem. 1982, 238, 79 ± 85.
Experimental Section
7: Alkylation of 1-(2-methoxyphenyl)piperazine (Fluka) with ethyl bro-
moacetate for 24 h at room temperature in the presence of Hünigꢁs base,
and purification on silica gel (CH2Cl2/ethylacetate 4:1 v/v) afforded 6a in
65 ± 70% yield. NaCp was freshly prepared in situ from Na (0.3 g,
12.7 mmol) and the corresponding amount of freshly distilled dicyclopen-
tadiene. Compound 6a in THF (1.8 g, 6.4 mmol) was added to the NaCp
solution and heated at about 608C for 6 h to afford a precipitate, which was
isolated by filtration under N2. The solid was washed several times with n-
hexane to leave an almost colorless powder, which was recrystallized from
hot THF to give analytically pure 7. 1H NMR (200 MHz, D2O): d 7.0 (m,
4H), 6.60 (brs, 2H), 6.15 (brs, 1H), 6.06 (brs, 1H), 3.74 (s, 3H), 3.50 (s,
2H), 2.95 (brs, 4H), 2.70 (brs, 4H); 13C NMR (300 MHz, D2O): d 182.4,
150.4, 138.2, 122.5, 122.2, 119.1, 116.9, 116.5, 115.9, 114.2, 111.3, 109.7, 59.8,
53.0, 50.5, 48.1.
[15] K. Hafner, G. Schulz, K. Wagner, Justus Liebigs Ann. Chem. 1964, 678,
39 ± 48.
8: Compound 8 can be synthesized according to published routes, starting
from [ReBr(CO)5] or directly from an aqueous buffer solution. (NEt4)2-
[ReBr3(CO)3] (130 mg, 0.15 mmol) in phosphate buffer (15 mL) was added
dropwise over a period of 2 h to compound 7 (70 mg, 0.18 mmol) dissolved
in phosphate buffer (15 mL, pH 7.4). The mixture was heated for 3 h at
758C, causing a brownish precipitate containing the product, as shown by
using HPLC. The precipitate was filtered and dissolved in CH2Cl2.
Separation of the product was performed by silica-gel column chromatog-
raphy. Elution with CH2Cl2 gave nonpolar side products, whereas
subsequent elution with CH2Cl2/2-propanol (80:1 v/v) gave compound 8
(20 mg, 23%). The product was recrystallized from an acidic mixture of
EtOH/water by slow evaporation of ethanol. 1H NMR (200 MHz, CD3CN):
d 6.9 (m, 4H), 6.24 (t, 2H), 5.53 (t, 2H), 3.79 (s, 3H), 3.48 (s, 2H), 3.05 (t,
[16] S. K. Kulkarni, K. O. Aley, Drugs Today 1988, 24, 175 ± 183; R. A.
Glennon, R. B. Westkaemper, P. Bartyzer in Serotonin Receptor
Subtypes (Ed.: S. J. Peroutka), Wiley, New York, 1991, pp. 19 ± 64;
I. A. Cliffe, A. Fletcher, Drugs Future 1993, 18, 631 ± 642; A. A.
Wilson, T. Inaba, N. Fischer, L. M. Dixon, J. Nobrega, J. N. DaSilva, S.
Houle, Nucl. Med. Biol. 1998, 25, 769 ± 776.
[17] R. Alberto, R. Schibli, A. Egli, U. Abram, S. Abram, T. A. Kaden,
P. A. Schubiger, Polyhedron 1998, 17, 1133 ± 1140.
[18] Crystallographic analysis: 10 (C21H22ClN2O5Re), colorless column,
0.19 Â 0.08 Â 0.03 mm3, monoclinic, space group P21/c, a
22.8795(14), b 14.0402(11), c 7.1351(4) , b 94.495(7)8, V
2285.0(3) 3, Z 4, 1calcd 1.756 gcm 3, R1 (I ꢁ 2s(I)) 0.0325, wR2
(F 2) 0.1090 for 22230 data (5468 independent, 1263 observed
Angew. Chem. Int. Ed. 2001, 40, No. 16
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2001
1433-7851/01/4016-3065 $ 17.50+.50/0
3065